Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 801 to 825 of 2529

TitleReference numberPublishedLast updated
Babies, children and young people's experience of healthcareNG204
Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangementTA722
Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroidsHTG590
Magnetic resonance therapy for knee osteoarthritisHTG588
Laparoscopic removal of uterine fibroids with power morcellationHTG589
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16sNG202
Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndromeTA139
Antenatal careNG201
Venous thromboembolism in adultsQS201
Melatonin for treating sleep disorders in adults who are blindES38
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphomaTA720
Antimicrobial prescribing: delafloxacin for community-acquired pneumoniaES37
MMprofiler for prognostic risk classification in multiple myelomaMIB270
Patient Status Engine for wireless monitoring of vital signsMIB271
Lung texture analysis for measuring interstitial lung diseasesMIB272
Bronchiolitis in children: diagnosis and managementNG9
Immunoscore for predicting risk of colon cancer relapseMIB269
Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiencyTA716
Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhageHTG587
Clostridioides difficile infection: antimicrobial prescribingNG199
Duvelisib for treating relapsed follicular lymphoma after 2 or more systemic therapies (terminated appraisal)TA717
ENDURALIFE powered CRT-D devices for treating heart failureHTG433
Ixekizumab for treating active ankylosing spondylitis and non-radiographic axial spondyloarthritisTA718
Secukinumab for treating active non-radiographic axial spondyloarthritisTA719
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failedTA715

Results per page

  1. 10
  2. 25
  3. 50
  4. All